共 50 条
- [1] Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non-Small-Cell Lung CancerCLINICAL LUNG CANCER, 2023, 24 (07) : 598 - 612Aung, Wint Yan论文数: 0 引用数: 0 h-index: 0机构: Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Manhasset, NY USA Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Manhasset, NY USA论文数: 引用数: h-index:机构:Morales, Jaclyn论文数: 0 引用数: 0 h-index: 0机构: North Shore Univ Hosp, Dept Clin Med Lib, Manhasset, NY USA Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Manhasset, NY USARahman, Husneara论文数: 0 引用数: 0 h-index: 0机构: Feinstein Inst Med Res, Inst Hlth Syst Sci, Biostat Unit, Manhasset, NY USA Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Manhasset, NY USASeetharamu, Nagashree论文数: 0 引用数: 0 h-index: 0机构: Northwell Hlth, Zuckerberg Canc Inst, Div Med Oncol & Hematol, 1111 Marcus Ave, New Hyde Pk, NY 11042 USA Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Manhasset, NY USA
- [2] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysisTRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566Cai, Zijing论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R China Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R ChinaZhan, Ping论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Peoples R China Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R ChinaSong, Yong论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Peoples R China Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R ChinaLiu, Hongbing论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Peoples R China Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R ChinaLv, Tangfeng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R China Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Peoples R China East Zhongshan Rd 305, Nanjing 211100, Peoples R China Nanjing Med Univ, Jinling Hosp, Dept Resp Med, Nanjing, Peoples R China
- [3] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysisFRONTIERS IN ONCOLOGY, 2022, 12Yang, Fang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Clin Canc Inst, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaWang, Yucai论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Hematol, Rochester, MN USA Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaTang, Lin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ Med Sch, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaMansfield, Aaron Scott论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Med Oncol, Rochester, MN 55902 USA Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaAdjei, Alex A. A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Med Oncol, Rochester, MN 55902 USA Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaLeventakos, Konstantinos论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Med Oncol, Rochester, MN 55902 USA Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China论文数: 引用数: h-index:机构:Wei, Jia论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Clin Canc Inst, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaWang, Lifeng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Clin Canc Inst, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaLiu, Baorui论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Clin Canc Inst, Nanjing, Peoples R China Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R ChinaMolina, Julian R. R.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Div Med Oncol, Rochester, MN 55902 USA Nanjing Univ, Nanjing Drum Tower Hosp, Comprehens Canc Ctr, Affiliated Hosp,Med Sch, Nanjing, Peoples R China
- [4] Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysisECLINICALMEDICINE, 2025, 81Yao, Jiacheng论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaLi, Sihan论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaBai, Lu论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaChen, Jun论文数: 0 引用数: 0 h-index: 0机构: Shenyang Tenth Peoples Hosp, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaRen, Chengbo论文数: 0 引用数: 0 h-index: 0机构: Hebei North Univ, Affiliated Hosp 1, Dept Radiat Oncol, Zhangjiakou, Hebei, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaLiu, Tingting论文数: 0 引用数: 0 h-index: 0机构: Anshan Canc Hosp, Dept Radiat Oncol, Anshan, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaQiu, Jingping论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R ChinaDanga, Jun论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China
- [5] Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysisFRONTIERS IN PHARMACOLOGY, 2023, 14Liu, Zijing论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaXu, Tiankai论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaChang, Pengyu论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaFu, Weijia论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaWei, Jiaying论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaXia, Chengcheng论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaWang, Qiang论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaLi, Man论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaPu, Xiaoyu论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaHuang, Fuxue论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaGe, Chao论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaGao, Yan论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaGong, Shouliang论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaLiu, Chengjiang论文数: 0 引用数: 0 h-index: 0机构: Anhui Med Univ, Dept Gastroenterol Gen Practice, He Fei, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R ChinaDong, Lihua论文数: 0 引用数: 0 h-index: 0机构: Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China Jilin Univ, Dept Radiat Oncol, Hosp 1, Changchun, Peoples R China Jilin Univ, NHC Key Lab Radiobiol, Sch Publ Hlth, Changchun, Peoples R China Jilin Univ, Jilin Prov Key Lab Radiat Oncol & Therapy, Hosp 1, Changchun, Peoples R China
- [6] Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-AnalysisINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E6 - E6Xiao, T.论文数: 0 引用数: 0 h-index: 0机构: Western Univ, London, ON, Canada Western Univ, London, ON, CanadaVerma, S.论文数: 0 引用数: 0 h-index: 0机构: Western Univ, London, ON, Canada Western Univ, London, ON, CanadaBoldt, G.论文数: 0 引用数: 0 h-index: 0机构: Western Univ, London, ON, Canada Western Univ, London, ON, CanadaRajeh, A.论文数: 0 引用数: 0 h-index: 0机构: Western Univ, London, ON, Canada Western Univ, London, ON, CanadaBreadner, D.论文数: 0 引用数: 0 h-index: 0机构: LRCP, London, ON, Canada Western Univ, London, ON, CanadaRaphael, J.论文数: 0 引用数: 0 h-index: 0机构: Western Univ, London Hlth Sci Ctr, London, ON, Canada Western Univ, London, ON, Canada
- [7] Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysisFRONTIERS IN IMMUNOLOGY, 2023, 14Wu, Jing论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaNi, Tingting论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaDeng, Rong论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaLi, Yan论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaZhong, Qin论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaTang, Fei论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaZhang, Qi论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaFang, Chunju论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaXue, Yingbo论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaZha, Yan论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Nephrol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R ChinaZhang, Yu论文数: 0 引用数: 0 h-index: 0机构: Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China Guizhou Prov Peoples Hosp, Natl Hlth Commiss Key Lab Pulm Immune Related Dis, Guiyang, Guizhou, Peoples R China Guizhou Prov Peoples Hosp, Dept Med Oncol, Guiyang, Peoples R China
- [8] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysisTHORACIC CANCER, 2023, 14 (25) : 2536 - 2547Feng, Yu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R China Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Med Oncol, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaTao, Yunxia论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Affiliated Hosp, Dept Oncol, Xuzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaChen, Haizhu论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Phase Clin Trial Ctr 1,Breast Tumoe Ctr,Dept Med O, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaZhou, Yu论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Thorac Med Dept 2,Xiangya Sch Med, Changsha, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaTang, Le论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaLiu, Chenwei论文数: 0 引用数: 0 h-index: 0机构: Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Pharm, Xian, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaHu, Xingsheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Med Oncol,Natl Clin Res Ctr Canc,Natl Canc Ct, Beijing Key Lab Clin Study Anticanc Mol Targeted D, Beijing, Peoples R China
- [9] SAFETY AND EFFICACY FOLLOWING IMMUNE CHECKPOINT INHIBITORS THERAPIES IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIESINTERNAL MEDICINE JOURNAL, 2020, 50 : 5 - 5Xie, Wenhui论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Beijing, Peoples R China Peking Univ First Hosp, Beijing, Peoples R ChinaHuang, Hong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Beijing, Peoples R China Peking Univ First Hosp, Beijing, Peoples R ChinaXiao, Shiyu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Third Hosp, Beijing, Peoples R China Peking Univ First Hosp, Beijing, Peoples R ChinaZhang, Zhuoli论文数: 0 引用数: 0 h-index: 0机构: Peking Univ First Hosp, Beijing, Peoples R China Peking Univ First Hosp, Beijing, Peoples R China
- [10] Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysisINTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88Wang, Jiajun论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Thorac Surg, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Dept Thorac Surg, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China论文数: 引用数: h-index:机构:Xu, Shun论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Thorac Surg, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Dept Thorac Surg, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China